Oral Semaglutide Clinical Trials

4 actively recruiting trials across 1 location

Also known as: Rybelsus

Pipeline

Phase 3: 1Phase 4: 2

Top Sponsors

Novo Nordisk A/S2
University Medical Centre Ljubljana1
Massachusetts General Hospital1

Indications

Diabetes4
Type 2 Diabetes3
Metabolic Diseases1
Type 2 Diabetes Mellitus (T2DM)1
Genetic Predisposition1

Other3 trials

A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes

Phase 3

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Phase 4

SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary

Boston, Massachusetts1 trial

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

Massachusetts General Hospital

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.